Pharnext

0 Followers

About

Pharnext esPharnext is an advanced, clinical-stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext has two lead products in clinical development. PXT3003 is currently in an international Phase 3 trial for the treatment of Charcot-Marie-Tooth disease type 1A and benefits from orphan drug status in Europe and the Unit...

Website
pharnext.com
Headquarters
Issy-les-Moulineaux, France
Industries
Biotechnology
Employees
11-50
Social

Photos

Add photos to showcase Pharnext’s culture

Values

Add Pharnext’s values

Insider experiences

Share your experience of working at Pharnext

Org chart

View org chart

David Horn Solomon

CEO & Board Member

Collapse

Adrian Hepner

Chief Medical Officer

François Chamoun

General Counsel

Muriel Cottard

Chief Quality Officer

Peter Collum

Chief Financial Officer and Chief Business Officer

Philippe Rinaudo

Chief Data Science Officer

Rodolphe Hajj

Chief Pharmacology Officer

Serguei Nabirotchkin

Co-Founder, Chief Biology Officer

Susanne Dorn

Chief Regulatory Officer

Viviane Bertrand

Chief Preclinical Drug Development Officer

Xavier Paoli

VP, Chief Commercial Officer

View org chart

Teams

View all (0)

Add your teams to show how people work together at Pharnext

Jobs

View all (0)

Add jobs to your org chart to show candidates who they’ll work with

Wires

View all (0)

Publish company announcements to get more exposure

Similar organizations

Explore 190,000+ org charts

Start exploring

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.